Robilink Dsr Capsule

This medication is indicated for treating GERD (Gastro-esophageal reflux disease), which does not respond to Rabeprazole medications alone. It prevents the tendency of vomiting and nausea in people suffering from gastrointestinal problems.

Robilink Dsr Capsule is a combination of Domperidone and Rabeprazole. The active ingredients fall under the class of dopamine antagonist and PPI (Proton pump inhibitor), respectively.

It is also prescribed to the patients of peptic ulcer and who take certain medicines for Parkinson’s disease. The medicine tightens the muscles near the entrance of the stomach and relaxes the ones present at the exit.

The action of this medication helps to speed up the passing of the food that you intake - from your stomach to your intestine, reducing the feeling of nausea and sickness, also preventing vomiting.

This medicine also works by blocking or reducing the stimulation in the ‘vomiting centre’ of your brain, which will eventually reduce the feeling of nausea and vomiting. The possible side effects of taking this medication can be headache, migraine, dryness of the mouth or breast pain.

You are advised not to take Robilink Dsr Capsule if you have the following conditions:

• An allergy to Robilink Dsr Capsule or any other ingredient of this medicine
• Bleeding problems or blockage in your stomach or in the intestine
• Tumour in the pituitary gland
• Cardiac disease
• Incorrect levels of magnesium, potassium or calcium in the blood
• Severe/moderate liver impairment

• Gastroesophageal Reflux Disease

• Peptic Ulcer

• Allergy

• Tumor Of Pituitary Gland

• Heart Diseases

• Skin Rash

• Diarrhoea

• Stomach Pain

• Headache

• Dizziness

• Weakness

• Insomnia

• Cough

• Rhinitis

• Flatulence

• Dry Mouth

• How long is the duration of effect?

  The effect of this medicine lasts up to 6 hours.

• What is the onset of action?

  The peak effect of this medicine can be observed within 30 to 60 minutes of administration.

• Are there any pregnancy warnings?

  This medicine is not recommended for use in pregnant women unless the potential benefits outweigh the risks involved. The effect of this medicine on the fetus is not clearly established and hence you are advised to consult a doctor before taking this medicine.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  This medicine is not recommended for use by breastfeeding mothers as there is a risk of side effects on the infant. You are advised to consult your doctors and consider the potential benefit and risks before consuming this medication.

Below is the list of medicines, which have the same composition, strength and form as Robilink Dsr Capsule , and hence can be used as its substitute.

• T Rab DSR Tablet

  Tetramed Biotek Pvt Ltd

• Raptac-Dsr Capsule

  Rapross Pharmaceuticals Pvt Ltd

• Pepzera D 30 Mg/20 Mg Capsule

  Pulse Pharmaceuticals

• Cidrid 30 Mg/20 Mg Capsule

  Profic Organic Ltd

• Rabex Capsule

  Xellence Laboratories

• Rolmizac D 30Mg/20Mg Capsule

  Arinna Lifescience Pvt Ltd

• Rabekind-Dsr Capsule

  Mankind Pharma Ltd

• RABRAL D 30MG/20MG TABLET

  Life Care Pharmaceuticals Pvt Ltd

• Rabera-DSR Capsule

  Jenburkt Pharmaceuticals Ltd

• Rabedal D Capsule

  Pharmed Ltd

• Are there any missed dose instructions?

  Skip the missed dose and resume with the next scheduled dose at the right time. The dose should not get doubled in an attempt to make up for the missed dose.

• Are there any overdose instructions?

  Contact your doctor if an overdose is suspected. Symptoms of overdose may include drowsiness, agitation, and convulsions and may be more prevalent in infants and children. Immediate medical attention including gastric lavage may be required in severe cases.

This medication attaches to the dopaminergic receptors without causing any release of the chemical dopamine. It, in turn, facilitates gastric emptying and decreases small bowel transit time. Also, it binds to H+/K+-exchanging ATPase in gastric parietal cells, resulting in blockage of acid secretion.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Alcohol

  Alcohol

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Interaction with Lab Test

  Lab

  The patients taking this medicine have been reported for false results, as it interacts with investigations of Neuroendocrine Tumors, Secretin Stimulation Test, Urine Tests for THC. Thus an alternative confirmatory test should be considered to verify the results.

• Interaction with Medicine

  null

  Concomitant use of Antiretrovirals, warfarin, methotrexate, digoxin, Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole, itraconazole), tacrolimus, antiarrhythmics, apomorphine, protease inhibitors, systemic azole antifungals, some macrolides (erythromycin, clarithromycin and telithromycin) is contraindicated.

• Interaction with Disease

  Kidney Disease

  Robilink Dsr Capsule should be used with caution if you are suffering from impaired kidney function. Suitable dose adjustment and safety monitoring is advised, especially if the impairment is severe.

  Liver Disease

  Robilink Dsr Capsule should be used with caution if you are suffering from impaired liver function. Suitable dose adjustment and safety monitoring is advised, especially if the impairment is mild to moderate. For severe impairment, use of this medicine is not recommended.

  Intestinal Disorders

  Robilink Dsr Capsule should be used with extreme caution in people having serious intestinal problems like internal bleeding, an obstruction or perforation of the stomach and intestine. Use of an alternate medicine is advised in such cases.

• Interaction with Food

  Food

  Information not available.

• Ques : what is Robilink Dsr Capsule used for?

  Ans : This medication is used for causes mentioned below:

  • GRD (gastroesophageal reflux disease)
  • Erosive esophagitis
  • Gastro-duodenal ulcers
  • Zollinger-ellison syndrome

• Ques : Is Robilink Dsr Capsule safe during pregnancy?

  Ans : This active ingredient of this medication belongs to a medicine group called PPI (pantoprazole) and Dopamine antagonist (domperidone). It never shown any risk to the baby, as there are no studies or human experiments data is available on it, which establish or proves any risk to the baby. Although, this medication is considered safe to consume during pregnancy.

• Ques : What is the best time of day to take Robilink Dsr Capsule?

  Ans : The best time to take this medication is to consume it empty stomach or before the first meal. But it is not adequate for the patients who have known allergies to Robilink Dsr Capsule or other medication of the same group.

• Ques : Is Robilink Dsr Capsule safe while breastfeeding?

  Ans : This medicine is not adequate for the use of breastfeeding unless it’s extremely necessary. Consult your doctor about all the risks and benefits before consuming this medication.

• Ques : How long do I need to use Robilink Dsr Capsule before I see improvement in my condition?

  Ans : This medication is to be taken till the time you see an improvement in your health conditions.

• Ques : At what frequency do I need to use Robilink Dsr Capsule?

  Ans : This medication should be taken in the dosage as prescribed by the doctor.

• Ques : What are the instructions for the storage and disposal of Robilink Dsr Capsule?

  Ans : This medication should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets.

• Domperidone- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2020 [Cited 28 February 2020]. Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/domperidone

• Domperidone- DrugBank [Internet]. Drugbank.ca. 2005 [Cited 28 February 2020]. Available from:

  https://www.drugbank.ca/drugs/DB01184

• Rabeprazole- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2020 [Cited 28 February 2020]. Available from:

  https://druginfo.nlm.nih.gov/drugportal/rn/117976-89-3

• Rabeprazole- DrugBank [Internet]. Drugbank.ca. 2005 [Cited 28 February 2020]. Available from:

  https://www.drugbank.ca/drugs/DB01129